Literature DB >> 2834437

Interaction of CD2 with its ligand, LFA-3, in human T cell proliferation.

B E Bierer1, J Barbosa, S Herrmann, S J Burakoff.   

Abstract

Recently, it has been demonstrated that lymphocyte function-associated Ag (LFA-3) is a natural ligand for CD2 and that this receptor-ligand interaction functions in cell-cell adhesion. In this report, we demonstrate that LFA-3 plays a role in T cell activation. L cells were transfected with human genomic DNA and sorted for expression of LFA-3. We demonstrate that LFA-3+ L cells, together with anti-CD3 mAb or with suboptimal doses of PHA, stimulate proliferation of human peripheral blood T cells. Furthermore, thymocyte proliferation was induced by LFA-3+ L cells and suboptimal doses of PHA. Proliferation was inhibited by mAb directed against either CD2 or LFA-3. Stimulation of thymocytes by the combination of PHA and LFA-3+ L cells resulted in the increased expression of the IL-2R, as well as of the surface Ag 4F2, transferrin receptor, and HLA-DR. These data support the conclusion that LFA-3 plays a role in CD2-dependent T cell activation. LFA-3 is widely distributed and is expressed on all APC and target cells. Thus, the ability of the CD2/LFA-3 interaction to costimulate with an anti-CD3 mAb suggests that the CD2/LFA-3 interaction may be involved not only in an Ag-independent alternate pathway of T cell activation but also in Ag-specific T cell activation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2834437

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells.

Authors:  M B Teunissen
Journal:  Histochem J       Date:  1992-10

2.  Costimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT DNA binding.

Authors:  E Parra; M Varga; G Hedlund; T Kalland; M Dohlsten
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

3.  The selective antigen-presenting cell capacity of activated B lymphocytes in HLA-II-restricted responses of CD4+ T lymphocytes.

Authors:  T T Van Der Pouw Kraan; F E Stiekema; M B Teunissen; J D Bos; L Kapsenberg
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

4.  Monoclonal antibodies specific for murine CD2 reveal its presence on B as well as T cells.

Authors:  H Yagita; T Nakamura; H Karasuyama; K Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

5.  Adhesion molecule mapping in normal human skin.

Authors:  U Konter; I Kellner; E Klein; R Kaufmann; V Mielke; W Sterry
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 6.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

7.  Different regulatory effects of pentoxifylline on human T cell activation pathways.

Authors:  R P Dong; Y Umezawa; H Ikushima; Y Munakata; S F Schlossman; C Morimoto
Journal:  J Clin Immunol       Date:  1997-05       Impact factor: 8.317

8.  Superantigen activation of CD4+ and CD8+T cells from HIV-infected subjects: role of costimulatory molecules and antigen-presenting cells (APC)

Authors:  J Vingerhoets; M Dohlsten; G Penne; R Colebunders; D Sansom; E Bosmans; L Kestens; G Vanham
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

9.  Antibody-induced mitogenicity mediated by a chimeric CD2-c-fms receptor.

Authors:  M F Roussel; C Transy; J Y Kato; E L Reinherz; C J Sherr
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

10.  Antibody-induced modulation of CD26 surface expression.

Authors:  T Mattern; C Reich; M Duchrow; S Ansorge; A J Ulmer; H D Flad
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.